LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

NCT03725605 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

COMBINATION_PRODUCT: LTX-315 and TILs

Sponsor

Lytix Biopharma AS

Collaborators

[object Object]